176 related articles for article (PubMed ID: 3774085)
21. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
Asad SN; Olmer AJ; Letteri JM
Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
[TBL] [Abstract][Full Text] [Related]
22. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems I. Investigation of propofol binding in model HSA solution.
Dawidowicz AL; Kobielski M; Pieniadz J
Eur J Pharm Sci; 2008 May; 34(1):30-6. PubMed ID: 18374549
[TBL] [Abstract][Full Text] [Related]
23. Drug therapy. Binding of drugs to serum albumin (second of two parts).
Koch-Weser J; Sellers EM
N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
[No Abstract] [Full Text] [Related]
24. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.
Niwa T
Semin Nephrol; 1996 May; 16(3):167-82. PubMed ID: 8734460
[TBL] [Abstract][Full Text] [Related]
25. Partial purification and characterization of the drug-binding-defect inducer in uremia.
Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
J Lab Clin Med; 1981 Jan; 97(1):72-81. PubMed ID: 7452082
[TBL] [Abstract][Full Text] [Related]
26. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
27. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
[TBL] [Abstract][Full Text] [Related]
28. How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases?
Kawasaki CI; Nishi R; Uekihara S; Hayano S; Kragh-Hansen U; Kawasaki CI; Otagiri M
Clin Toxicol (Phila); 2005; 43(2):95-9. PubMed ID: 15822760
[TBL] [Abstract][Full Text] [Related]
29. A new procedure for the removal of protein bound drugs and toxins.
Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
[TBL] [Abstract][Full Text] [Related]
30. Underestimation of albumin content by bromocresol green, induced by drug displacers and uremia.
Calvo R; Carlos R; Erill S
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):76-8. PubMed ID: 3988397
[TBL] [Abstract][Full Text] [Related]
31. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
32. [Pathologic change of serum albumin in chronic renal failure: human mercapt/nonmercaptoalbumin and endogenous drug binding inhibitor].
Tsuruta Y; Maeda K
Rinsho Byori; 1987 Sep; 35(9):975-80. PubMed ID: 3430773
[No Abstract] [Full Text] [Related]
33. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
Tillement JP; Duché JC; Barré J
Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
[TBL] [Abstract][Full Text] [Related]
34. Effect of blood sampling schedules on protein drug binding in the rat.
Hulse M; Feldman S; Bruckner JV
J Pharmacol Exp Ther; 1981 Aug; 218(2):416-20. PubMed ID: 6166741
[TBL] [Abstract][Full Text] [Related]
35. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
[TBL] [Abstract][Full Text] [Related]
36. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?
Florens N; Yi D; Juillard L; Soulage CO
Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629
[TBL] [Abstract][Full Text] [Related]
37. Free drug monitoring.
Chan S; Gerson B
Clin Lab Med; 1987 Jun; 7(2):279-87. PubMed ID: 3301170
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
Keller F; Maiga M; Neumayer HH; Lode H; Distler A
Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
[TBL] [Abstract][Full Text] [Related]
39. Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs.
Pacifici GM; Viani A; Taddeucci-Brunelli G; Rizzo G; Carrai M; Schulz HU
Ther Drug Monit; 1986; 8(3):259-63. PubMed ID: 3750366
[TBL] [Abstract][Full Text] [Related]
40. [Endogenous metabolites as modulators of the transport of drugs by serum albumin].
Bender KI; Lutsevich NF; Lutsevich AN; Kupchikov VV
Farmakol Toksikol; 1990; 53(3):72-80. PubMed ID: 2201566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
